Psilocybin for major depressive disorder: a systematic review of randomized controlled studies
Frontiers in Psychiatry September 23, 2024 Zhan-Ming Shi, Yu-Ping Ning, Xin-Hu Yang et al. 21 citations
Objectives The purpose of this systematic review of randomized controlled trials (RCTs) was to evaluate the effectiveness, safety, and tolerability of psilocybin in adult patients with major depressive disorder (MDD). Methods A systematic search (up to September 14, 2023) was conducted for RCTs that examined the efficacy, safety, and tolerability of psilocybin in physically healthy adult...